申请人:Bannen Canne Lynne
公开号:US20070054928A1
公开(公告)日:2007-03-08
The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. More specifically, the invention provides quinazolines and quinolines which inhibit, regulate and/or modulate kinase receptor, particularly c-Met, KDR, c-Kit, flt-3 and flt-4, signal transduction pathways related to the changes in cellular activities as mentioned above, compositions which contain these compounds, and methods of using them to treat kinase-dependent diseases and conditions. The present invention also provides methods for making compounds as mentioned above, and compositions which contain these compounds.
本发明提供了用于调节蛋白激酶酶活性以调节细胞活动(如增殖、分化、程序性细胞死亡、迁移和化学入侵)的化合物。更具体地,本发明提供了能够抑制、调节和/或调节激酶受体,特别是c-Met、KDR、c-Kit、flt-3和flt-4,与上述细胞活动变化相关的信号转导途径的喹唑啉和喹啉,以及包含这些化合物的组合物和使用它们治疗激酶依赖性疾病和病况的方法。本发明还提供了制备上述化合物和包含这些化合物的组合物的方法。